Melanoma is the most malignant type of skin cancer. Early detection of melanoma is thus critical for patient prognosis and survival. At present, examination by a skilled dermatologist followed by biopsy of suspicious lesions is the diagnostic gold standard. The aim of the present study was to examine an alternative and noninvasive method for the diagnosis of melanoma at an early stage. We identified and compared the volatile organic compounds (VOCs) in mouse urine and feces, before and after a subcutaneous injection of B16 melanoma cells. We identified a total of 16 VOCs in urine and 13 VOCs in feces that could serve as potential biomarkers. Statistical analysis significantly discriminated between the cancer and control groups. These results should be validated in a larger-scale animal study, after which a study could be designed in patients to develop a melanoma biomarker.
Keyphrases
- skin cancer
- early stage
- end stage renal disease
- ejection fraction
- chronic kidney disease
- ultrasound guided
- peritoneal dialysis
- newly diagnosed
- case report
- basal cell carcinoma
- squamous cell carcinoma
- prognostic factors
- radiation therapy
- fine needle aspiration
- patient reported outcomes
- quantum dots
- lymph node metastasis
- label free
- loop mediated isothermal amplification
- locally advanced
- silver nanoparticles